… in our scoping review reported mild adverse events after … participants will shed light on the
efficacy and safety of the antiviral. … the efficacy and safety of remdesivir for patients with mild or …

… Asbrip in mild to moderate COVID-19 patients. The results of Viusid-Asbrip group compared
to control group shows that it can help to favors the recovery of the COVID-19 patients and …

… This study aimed to evaluate the real-world effectiveness of Azvudine among COVID-19
nonhospitalized patients. This was a retrospective cohort study, looking at nonhospitalized …

… the efficacy of ivermectin for COVID-19 patients with mild to moderate disease. … COVID-19,
all possible confounders can never be reliably ruled out. However, as the cases of COVID-19 …

… In this double-blind, randomized, placebo-controlled trial, we examined the efficacy and
safety of Ivermectin at two doses (24 mg and 12 mg) in the management of non-severe …

… Favipiravir has demonstrated efficacy against the SARS-CoV-2 virus in several preliminary
… to evaluate the efficacy and safety of favipiravir for treatment of mild to moderate COVID-19 in …

… of the efficacy and safety of molnupiravir in treating patients with mild to moderate COVID-19. …
has clinical benefits for non-severe COVID-19 patients, suggesting that healthcare workers …

… non-hospitalised adults with mild to moderate COVID-19 has potential to prevent disease …
safety and efficacy of tixagevimab–cilgavimab in preventing progression to severe COVID-19 …

… studies of IFN in COVID-19 by evaluating orally-inhaled nebulized IFN-β1a and evaluating
both safety and efficacy in adult outpatients with mild-to-moderate COVID-19. In this phase 2 …

… Regdanvimab has shown a promising safety profile in phase 1 studies in healthy … with mild
COVID-19 and exhibited potential antiviral and clinical efficacy in patients with mild COVID-19 …